Search
Now showing items 1-7 of 7
The importance of MicroRNA 29a as a biomarker in colon cancer
(Genetics & Molecular Medicine, 2022)
Introduction: Colon cancer (CC) has become one of the most common diseases in recent years.The incidence of
(CC) varies greatly worldwide, depending on lifestyle, environment, and genetic causes. Endoscopy is invasive ...
The importance of MicroRNA 106b as a biomarker in gastric cancer
(Japanese Journal of Gastroenterol Research, 2022)
Objective: Gastric cancer (GC) is the fourth most common malignant disease worldwide, and it is observed 2-3 times more frequently in men than in women. It is important to make an early diagnosis in GC, by using screening ...
The role of microRNAs as biomarker in pancreas cancer
(Japanese Journal Gastroeneterology Research, 2022)
Objective: Pancreatic cancer (PC) is an aggressive cancer of the digestive tract Overall survival for patients with pancreatic cancer is poor mainly due to the lack of biomarkers that enable early diagnosis. Several studies ...
MicroRNAs as a biomarker in lung cancer
(Mattioli, 2023)
Introduction: Lung cancer (LC) is the most common cancer in the world.Well known causes are
long term smoking, environmental influences and genetic variations. LC is divided into two main types based
on their histological ...
Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer
Introduction: Prostate cancer (PCa) is a common type of cancer in western countries and prominent cause of mortality in men. The aim of the study was to evaluate miRNAs as biomarkers in PCa in healthy individuals and ...
The miR125b as biomarkers in the early diagnosis of bladder cancer
(Genetics & Molecular Medicine, 2022)
Objective: Bladder cancer (BCa) is the fifth most common cancer and the second most common urinary tract cancer in worldwide. BCa accounts for 3% of all cancers and is particularly common in developed countries.
Material ...
The importance of Microrna21 as biomarker in hepatocellular carcinoma
(Genetics & Molecular Medicine, 2022)
Objective: Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading cause of cancerrelated
deaths worldwide.The diagnosis of HCC patients remains difficult, especially early in the development ...